Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Outcome of Anti-IL6 and Corticosteroid Monotherapy vs Combination in COVID-19 Cytokine Release Syndrome

NCT04486521 is registered in ClinicalTrials.gov with King Faisal Specialist Hospital & Research Center as lead sponsor.

NCT NCT04486521
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04486521 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Outcome of Anti-IL6 and Corticosteroid Monotherapy vs Combination in COVID-19 Cytokine Release Syndrome
Lead sponsor
King Faisal Specialist Hospital & Research Center
Phase
Observational
Overall status
Unknown status
Start date
July 22, 2020
Completion date
July 22, 2021
Enrollment
860 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

corona virus infection, critical illness, cytokine release syndrome